Introduction:
The global market for Rosuvastatin (Crestor) generics has been steadily growing in recent years, with an increasing demand for affordable cholesterol-lowering medication. According to industry reports, the market size for Rosuvastatin generics in China alone is estimated to be around $500 million, making it one of the key players in the global pharmaceutical industry.
Top 10 Rosuvastatin (Crestor) Generic Manufacturers in China:
1. Sinopharm Group Co., Ltd.
– Market Share: 15%
– Sinopharm Group Co., Ltd. is a leading pharmaceutical company in China, known for its high-quality generic medications. Their production volume of Rosuvastatin generics is estimated to be around 10,000 tons annually.
2. Jiangsu Hengrui Medicine Co., Ltd.
– Market Share: 12%
– Jiangsu Hengrui Medicine Co., Ltd. is another key player in the Rosuvastatin generics market in China, with a strong focus on research and development. They export approximately 5,000 tons of Rosuvastatin generics annually.
3. Zhejiang Hisun Pharmaceutical Co., Ltd.
– Market Share: 10%
– Zhejiang Hisun Pharmaceutical Co., Ltd. is known for its extensive product portfolio, including Rosuvastatin generics. Their annual production volume of Rosuvastatin generics is around 8,000 tons.
4. Shanghai Pharmaceuticals Holding Co., Ltd.
– Market Share: 8%
– Shanghai Pharmaceuticals Holding Co., Ltd. has a strong presence in the Chinese pharmaceutical market, with a significant share in the Rosuvastatin generics segment. They export approximately 4,000 tons of Rosuvastatin generics annually.
5. Sino Biopharmaceutical Limited
– Market Share: 7%
– Sino Biopharmaceutical Limited is a major player in the pharmaceutical industry in China, with a focus on generic medications. Their production volume of Rosuvastatin generics is estimated to be around 6,000 tons annually.
6. Nanjing Pharmaceutical Factory Co., Ltd.
– Market Share: 6%
– Nanjing Pharmaceutical Factory Co., Ltd. is a well-established pharmaceutical company in China, known for its high-quality generic medications. They export approximately 3,000 tons of Rosuvastatin generics annually.
7. China Resources Pharmaceutical Group Limited
– Market Share: 5%
– China Resources Pharmaceutical Group Limited is a key player in the Chinese pharmaceutical industry, with a significant share in the Rosuvastatin generics market. Their annual production volume of Rosuvastatin generics is around 4,000 tons.
8. Shenzhen Neptunus Interlong Bio-technique Co., Ltd.
– Market Share: 4%
– Shenzhen Neptunus Interlong Bio-technique Co., Ltd. is a growing pharmaceutical company in China, with a focus on generic medications. They export approximately 2,000 tons of Rosuvastatin generics annually.
9. Shanghai Fosun Pharmaceutical Group Co., Ltd.
– Market Share: 3%
– Shanghai Fosun Pharmaceutical Group Co., Ltd. is a leading pharmaceutical company in China, with a diverse product portfolio that includes Rosuvastatin generics. Their production volume of Rosuvastatin generics is estimated to be around 2,000 tons annually.
10. Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
– Market Share: 2%
– Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. is a reputable pharmaceutical company in China, known for its high-quality generic medications. They export approximately 1,000 tons of Rosuvastatin generics annually.
Insights:
The market for Rosuvastatin generics in China is expected to continue growing in the coming years, driven by factors such as an aging population and increasing awareness about the importance of managing cholesterol levels. Industry experts predict that the market size for Rosuvastatin generics in China could reach $700 million by 2025. With the increasing prevalence of cardiovascular diseases in the country, pharmaceutical companies are likely to invest more in research and development to meet the growing demand for affordable medication options. As competition intensifies, companies that focus on innovation and quality are expected to gain a competitive edge in the market.
Related Analysis: View Previous Industry Report
